Formulary Search
A to Z of Drugs : D
Records returned : 183 (on 29 May 2025 at 01:42:50).
Show Icon and Status Keys
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Specialist initiation and at least one month supply before transfer to primary care.
Reserved for use where apixaban / rivaroxaban are not suitable
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sachets (granules)
Restrictions / Comments:
Important
Not assessed for inclusion on the formulary. Contact pharmacy team for advice on making an application.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Restricted Antimicrobial - requires Microbiology Specialist Approval.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Links :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Excluding obstetric and cancer patients.
Specialist initiation and at least one month supply before transfer to primary care.
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Off-label use
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Heamatology only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
Restrictions / Comments:
Important
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
Restrictions / Comments:
Important
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
If a patient with diabetes were on insulin and on multiple other treatments, a discussion with the specialist team may be prudent prior to dapagliflozin initiation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Type 2 diabetes.
Empagliflozin is the preferred SGLT-2
Dapagliflozin is not a preferred treatment option.
Trusts restrict to diabetic team initiation only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Not licensed in Type 1 diabetes. Not to be initiated in new Type 1 patients.
Shared care remains in place for existing patients only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Empagliflozin is the preferred SGLT2.
Reserve combination products for patients in whom separate components are less appropriate.
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Restricted Antimicrobial - requires Microbiology Specialist Approval.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Heamatology team only.
NOT for dialysis-induced anaemia - this is not commissoned from any Surrey Heartlands Trusts.
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
NHSE commissioned services only. This is NOT commissoned from any Surrey Heartlands Trusts.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Switch to solifenacin recommended (if appropriate)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Suspension
- Tablets
Restrictions / Comments:
Important
Restricted Antimicrobial - requires GUM Specialist Approval
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted Antimicrobial - requires GUM Specialist approval
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Requires approval from HCV national team for use
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
For Transfusion-related iron overload.
Not for use in thalassemia or sickle cell - NHSE commissioned services only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE commissioned services only. This is NOT commissoned from any Surrey Heartlands Trusts.
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
Only licensed for the NHSE commissioned indications. Therefore, not for use in Surrey Heartlands Trusts
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE commissioned services only. This is NOT commissoned from any Surrey Heartlands Trusts.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Initiation and 1st month supply by the specialist team before any request for primary care prescribing.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
ONLY after post single anastomosis duodenal illeal bypass with sleeve (SADI-S) or duodenal switch surgery.
Prescribing by primary care on recommendation from specialist team.
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cream
Restrictions / Comments:
Important
Not assessed for inclusion on the formulary. NICE guidance is anticipated in Aug 25. Advice will be updated post-NICE.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Tablets
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
Formulary Status :
Links :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Initiation and stabilisation by the specialist team for a minimum of 3 months before any request for primary care prescribing.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Biosimilar - prescribe by brand.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Rheumatology only in secondary care.
Restricted to use in patients for whom bisphosphonates are unsuitable.
Patients with a CKD of 4 or 5 and patients with a T-score of < -4.5 to remain under specialist care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
For Transfusion-related iron overload.
Not for use in thalassemia or sickle cell - NHSE commissioned services only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE commissioned services only. This is NOT commissoned from any Surrey Heartlands Trusts.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Not a 1st-line option.
Use cetirizine or loratadine 1st line.
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Loratadine liquid is 1st line in patients unable to swallow tablets (from 2 years of age)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Initiation in Primary Care on recommendation from the specialist team.
Prescribe generically.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sublingual tablets
Restrictions / Comments:
Important
Initiation in Primary Care on recommendation from the specialist team.
Prescribe generically.
Links :
Indication :
Status :
Formulations :
- Oral lyophilisates
Restrictions / Comments:
Important
Initiation in Primary Care on recommendation from the specialist team.
Note - In Primary Care, sublingual tablets are lower cost than oral lyophilisates. Consider the use of sublingual tablets if appropriate.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Nasal spray
Restrictions / Comments:
Important
Initiation in Primary Care on recommendation from the specialist team.
10mcg nasal spray.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Initiation in Primary Care on recommendation from the specialist team.
4mcg/ml injection.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
For haemophilic / von Willebrand patients undergoing surgery / following trauma.
Available as:
4mcg/ml (DDAVP)
15mcg/ml (Octim) - much more expensive. Useful when lower volume is required
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Initiation in Primary Care on recommendation from the specialist paediatric team.
Prescribe generically.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sublingual tablets
Restrictions / Comments:
Important
Initiation in Primary Care on recommendation from the specialist paediatric team.
Prescribe generically.
Links :
Indication :
Status :
Formulations :
- Oral lyophilisates
Restrictions / Comments:
Important
Initiation in Primary Care on recommendation from the specialist paediatric team.
Note - In Primary Care, sublingual tablets are lower cost than oral lyophilisates. Consider the use of sublingual tablets if appropriate.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral lyophilisates
Restrictions / Comments:
Important
Initiation and 1 month supply by the specialist before any request for primary care prescribing.
Women - 25mcg dose
Men - 50mcg dose
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
- Subcutaneous injection (sc)
- Tablets
Restrictions / Comments:
Important
On recommendation of palliative care team
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
2nd line option. Requests for primary care prescribing on recommendation from specialist endocrinology team only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
Reserved for patients who are unable to swallow solid dose forms. Requests for primary care prescribing by the specialist endocrinology teams only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravitreal implant
Restrictions / Comments:
Important
Ophthalmology specialists only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
- Eye drops (preservative free
- unit dose)
Restrictions / Comments:
Important
Short-term use only. Primary Care prescribing on specialist recommendation
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
- Subcutaneous injection (sc)
- Tablets
Restrictions / Comments:
Important
On advice from palliative care specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
On request from the specialist / Cancer Centre
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
- Subcutaneous injection (sc)
- Tablets
Restrictions / Comments:
Important
On recommendation of palliative care team
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subconjunctival injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravitreal implant
Restrictions / Comments:
Important
Ophthalmology specialists only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
- Subcutaneous injection (sc)
- Tablets
Restrictions / Comments:
Important
On advice from palliative care specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravitreal implant
Restrictions / Comments:
Important
Ophthalmology specialists only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intra-articular injection
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Ear drops
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Spray
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
- Eye ointment
Restrictions / Comments:
Important
Short-term use only.
Primary Care prescribing on specialist recommendation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
Short term use.
GPs may prescribe a further supply to enable patients to complete their post-operative course.
Formulary Status :
Links :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
This entry has not yet been reviewed for inclusion on the joint formulary. However, this information has been published due to the ongoing requirement for prescribers to access the shared care agreement and other resources that were in place prior to the launch of the joint formulary.
Please refer to the list of agreed formulations and former traffic light status available on the PAD page (accessed by clicking the drug name).
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
RSFT only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Oral suspension
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Limited stock - restrictions apply. Contact Pharmacy.
Safety alert for High Dose
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Enema
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Rectal solution
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Always used in combination with chlorothiazide.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Unlicensed product
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
Restrictions / Comments:
Important
Unlicensed. RSCH only for use on SCBU.
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Gel
Restrictions / Comments:
Important
1%, 1.16% gels.
Diclofenac gel is the most costly option in primary care. Consider a lower cost alternative e.g. ibuprofen 5% gel or piroxicam 0.5% gel.
Links :
Indication :
Status :
Formulations :
- Suppositories
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Restricted to use when oral NSAIDs are not an option.
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Ibuprofen or naproxen are the preferred NSAIDS.
Diclofenac for use if 1st-line options are ineffective / not tolerated.
Restriced at Trusts to Rheumatology only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release capsules
- Modified release tablets
Restrictions / Comments:
Important
Ibuprofen or naproxen are the preferred NSAIDS.
Standard release diclofenac may be considered if 1st-line NSAIDs are ineffective / not tolerated.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
- Eye drops (preservative free
- unit dose)
Restrictions / Comments:
Important
Initiation by specialist team. Duration of treatment to be clarified if subsequent prescriptions are requested from primary care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Dispersible tablets
- Tablets
Restrictions / Comments:
Important
Restricted Antimicrobial - requires GUM Specialist approval
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
To be initiated and first 6 months treatment to be supplied by a specialist
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Initiation and 1st month supply by the specialist team before any request for primary care prescribing.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Elixir
- Tablets
Restrictions / Comments:
Important
ONE 62.5mcg tablet is equivalent to 50mcg (1ml) of elixir
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
ONE 62.5microgram tablet is approximately equivalent to 50microgram (1mL) elixir
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Consider use if standard release tablets are not tolerated or compliance is an issue.
Links :
Indication :
Status :
Formulations :
- Cream
Restrictions / Comments:
Important
2nd-line where patient has not tolerated GTN or this has been ineffective.
Use 2% ointment in preference to cream (unless ointment unavailable)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Ointment
Restrictions / Comments:
Important
2nd-line where patient has not tolerated GTN or this has been ineffective.
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Prescribe by BRAND
Tildiem Retard (TWICE daily) are the lowest cost brand in Primary Care for patients requiring a tablet formulation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release capsules
Restrictions / Comments:
Important
Prescribe by BRAND
Angitil SR capsules (TWICE daily) or Zemtard XL or Slozem (ONCE daily) are the lowest cost brands for Primary Care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Prescribe by BRAND
Tildiem Retard (TWICE daily) are the lowest cost brand in Primary Care for patients requiring a tablet formulation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release capsules
Restrictions / Comments:
Important
Prescribe by BRAND
Angitil SR capsules (TWICE daily) or Zemtard XL or Slozem (ONCE daily) are the lowest cost brands for Primary Care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
- Pessaries
- Vaginal gel
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
RSCH: Maternal vaccination
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release capsules
Restrictions / Comments:
Important
Not 1st-line. Alternative to clopidogrel and aspirin
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release capsules
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sachets
Restrictions / Comments:
Important
Preferred
On advice of stoma nurse only. Up to two boxes per month only
ABSORB ODOUR NEUTRALISING ABSORBENT GEL
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sachets
Restrictions / Comments:
Important
Preferred
On advice of stoma nurse only. Up to two boxes per month only
TRIO PEARL SACHETS
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sachets
Restrictions / Comments:
Important
On advice of stoma nurse only. Up to two boxes per month only
CONVATEC DIAMOND SACHETS
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
0.37% eye drops (unlicensed)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Specialist initiation and at least one month supply before transfer to primary care
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Specialist initiation and at least one month supply before transfer to primary care
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral solution
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Enema
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Ear drops
Restrictions / Comments:
Important
Available to purchase for self care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted Antimicrobial - requires GUM Specialist approval
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Important
Refer to MHRA cardiac safety alerts.
Off label use.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Important
Refer to MHRA cardiac safety alerts.
Off label use.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Important
Refer to MHRA cardiac safety alerts.
Off label use.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Important
Refer to MHRA cardiac safety alerts.
Off label use.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Important
ADULTS and adolescents over 12 years or weighing 35kg or more.
Use lowest effective dose for shortest possible duration (max 1 week)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Important
CHILDREN under 12 years: MHRA safet alert, In children younger than 12 years or patients weighing less than 35kg - restricted to secondary care for a duration of less than 1 week
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Important
Off-label use. On request from the specialist / Cancer Centre
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Important
Safety alert and cardiac side-effects.
2nd line treatment option but should not be prescribed for longer than 7 days.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
This drug has not yet been assessed for formulary status.
If a patient is accessing non-NHS supplies of this medication, refer to the NHSE information here (for a similar drug called lecanemab) which provides advice on potential adverse effects.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
This entry has not yet been reviewed for inclusion on the joint formulary. However, this information has been published due to the ongoing requirement for prescribers to access the shared care agreement and other resources that were in place prior to the launch of the joint formulary.
Please refer to the list of agreed formulations and former traffic light status available on the PAD page (accessed by clicking the drug name).
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Nebules
Restrictions / Comments:
Important
NHSE Specialised Commissioned services only.
GPs may continue to prescribe for their EXISTING patients only. All new patients are commissioned by NHSE.
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
Prescribe generically.
Initiation by specialist team before transfer of prescribing to primary care
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
- Eye drops (preservative free
- unit dose)
Restrictions / Comments:
Important
Prescribe generically.
Initiation by specialist team before transfer of prescribing to primary care
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Administer concurrent oxygen. Monitor ABG
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Immediate release tablets
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Use immediate release tablets
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Immediate release tablets
Restrictions / Comments:
Important
Step 4 of the hypertension pathway.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Step 4 of the hypertension pathway.
Use immediate release tablets
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Dispersible tablets
- Tablets
Restrictions / Comments:
Important
Follow local guidelines on the use of antimicrobials.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
For percutaneous sclerotherapy of lymphatic malformations, lymphoceles, recalcitrant cyst and postoperative seromas ONLY
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Gastro-resistant tablets
Restrictions / Comments:
Important
Not a preferred 1st-line option. Use only after failure of at least one established 1st-line treatment options
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Cardiology only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.
2nd line after desogestrel. Caution - may have different drug interactions to other progestogen-only pills.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Preferred
Preferred GLP-1 for WEEKLY injection.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Licensed only for diabetic peripheral neuropathic pain but also recommended as per NICE CG173 (off- label indication) as a treatment option in neuropathic pain.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialised commissioned services only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
Not assessed for inclusion on the formulary. Contact pharmacy team for advice on making an application.
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
Not assessed for inclusion on the formulary. Contact pharmacy team for advice on making an application.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :